Physicians Realty Trust
NYSE:DOC

Watchlist Manager
Physicians Realty Trust Logo
Physicians Realty Trust
NYSE:DOC
Watchlist
Price: 17.07 USD -1.9% Market Closed
Market Cap: $11.9B

Physicians Realty Trust
Investor Relations

In the intricate web of healthcare and real estate, Physicians Realty Trust weaves a unique narrative. Born in 2013, this real estate investment trust (REIT) has carved a niche as a diligent custodian of healthcare facilities across the United States. The company's primary mission is to acquire, develop, and manage high-quality healthcare properties, focusing predominantly on medical office buildings. These are not just any buildings; they're crucial infrastructural elements that serve as the points of intersection between surgery centers, clinical operations, and diagnostic services, all of which are vital to the functioning of modern healthcare systems. By entering into long-term lease agreements with a diverse range of healthcare providers, Physicians Realty Trust ensures a steady income stream, tethering its fortunes to the robust demand for healthcare services.

Revenue for Physicians Realty Trust flows primarily from these leasing arrangements, crafting its financial stability upon the bedrock of reliable occupancy rates and strategic location choices. The company's portfolio is designed to meet the evolving needs of healthcare providers, offering spaces that are essential for physicians to deliver quality patient care. Beyond the typical landlord-tenant dynamic, Physicians Realty Trust partners with healthcare institutions to support their growth and operational efficiency, engendering a symbiotic relationship. This emphasis on collaboration and adaptability allows the trust to not just collect rents, but to actively contribute to the healthcare ecosystem, thereby bolstering its own value proposition in the market. Through this model, Physicians Realty Trust thrives on not just the physical spaces it owns, but on the essential services its tenants provide, anchoring its financial success in the health of both its properties and the communities they serve.

Show more
Loading
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
Last Earnings Call
Fiscal Period
Q4 2025
Call Date
Feb 3, 2026
AI Summary
Q4 2025

2025 Results: Full-year FFO as adjusted was $1.84 per share, AFFO was $1.69 per share, both in line with the midpoint of original guidance.

Segment Performance: Outpatient medical and senior housing segments delivered strong operating results, with senior housing posting 17% same-store growth in Q4.

Life Science Headwinds: Life science (lab) segment faced a challenging environment, with occupancy ending at 77% and same-store NOI growth of 1.5% for the year.

2026 Guidance: FFO as adjusted is expected to range from $1.70 to $1.74 per share, with total same-store NOI growth between down 1% and up 1%. Lab NOI is expected to fall 5% to 10%.

Strategic Moves: Healthpeak completed a major Gateway campus acquisition in South San Francisco and is preparing to contribute its senior housing assets to Janus Living via an IPO.

Capital Activity: Over $464 million in acquisitions have already closed in 2026, with $1 billion or more of asset sales, recapitalizations, and loan repayments planned for the year.

Balance Sheet: Net debt to adjusted EBITDA ended at 5.2x, with $2.4 billion of liquidity.

Key Financials
FFO as adjusted (Q4 2025)
$0.47 per share
AFFO (Q4 2025)
$0.40 per share
FFO as adjusted (Full Year 2025)
$1.84 per share
AFFO (Full Year 2025)
$1.69 per share
Total same-store cash NOI growth (Q4 2025)
3.9%
Total same-store cash NOI growth (Full Year 2025)
4%
Outpatient Medical leasing (Full Year 2025)
4.9 million sq ft
Outpatient Medical new leasing (Full Year 2025)
1 million sq ft
Outpatient Medical cash re-leasing spreads
5% on renewals
Outpatient Medical tenant retention
79%
Outpatient Medical occupancy (year-end 2025)
91%
Outpatient Medical same-store growth (2025)
3.9%
Lab segment same-store NOI growth (2025)
1.5%
Lab segment occupancy (year-end 2025)
77%
Lab lease execution (Full Year 2025)
1.5 million sq ft
Lab new leasing (Full Year 2025)
562,000 sq ft
Lab cash re-leasing spreads
5% on renewals
Senior housing same-store NOI growth (Full Year 2025)
12.6%
Senior housing same-store NOI growth (Q4 2025)
16.7%
Net debt to adjusted EBITDA (year-end 2025)
5.2x
Liquidity (year-end 2025)
$2.4 billion
2026 Acquisitions completed (so far)
$464 million
Senior housing portfolio JV buyout
$314 million (3,400 units, 46.5% interest)
Senior housing investments under LOI/purchase agreement
$360 million
Asset sales (Q4 2025 outpatient medical)
$325 million (at a low 6% cap rate)
Planned asset sales/recaps/loan repayments (2026)
$1 billion or more
Planned refinancing activity (2026)
$1.1 billion (includes $650 million senior unsecured notes and $440 million secured mortgages)
2026 CapEx plan
Just over $500 million
Earnings Call Recording
Other Earnings Calls

Management

Mr. Scott M. Brinker
President, CEO & Director
No Bio Available
Mr. Scott R. Bohn
Chief Development Officer & Head of Lab
No Bio Available
Mr. Adam G. Mabry
Chief Investment Officer
No Bio Available
Mr. Shawn G. Johnston
Executive VP & Chief Accounting Officer
No Bio Available
Mr. Andrew Johns CFA
Senior Vice President of Investor Relations
No Bio Available
Mr. Jeffrey H. Miller
General Counsel
No Bio Available
Ms. Lisa A. Alonso
Executive VP & Chief Human Resources Officer
No Bio Available
Mr. James A. Croy
Senior Vice President of Leasing - Outpatient Medical
No Bio Available
Mr. Antonio Acevedo
Senior Vice President of Asset Management - Outpatient Medical
No Bio Available
Mr. Jameson J. Bennett
Senior Vice President of Outpatient Medical Finance
No Bio Available

Contacts

Address
WISCONSIN
Milwaukee
309 N Water St Ste 500
Contacts
+14143675600.0
www.docreit.com
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett